Ondansetron Reduce Vomiting Associated With Ketamine PSA

Completed · Not applicable · Has a placebo group

Conditions studied: Conscious Sedation

In brief

Ondansetron, a commonly used anti-vomiting medication, may reduce the occurrence of vomiting associated with ketamine during procedural sedation in the pediatric emergency department.

Key facts

Study ID

NCT00387556

Run by

University of Colorado, Denver

People needed

268

Starts

2002-12-01

Expected to finish

2006-12-01

Last updated by the study team

2013-05-13

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• age 1-21 years, ASA I or II, fracture of dislocation reduction

You may not qualify if…

• age < 1 year, ASA III or IV, hypertension, glaucoma, acute globe injury, increased intracranial pressure or central nervous system mass lesion, major psychiatric disorder, porphyria, previous adverse reaction to ketamine or ondansetron, parent, guardian or patient unwilling to provide informed consent.

Where it is running

• The Childrens Hospital — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.